GIVE MISS CALL ON :- +91 99774 99927

Tag Archives: ‪intraday stock tips

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 06 DEC 2018

The NSE benchmark Nifty opened the session with a downside gap and later shifted to sideways movement. Bouts of volatility were seen post the announcement of RBI’s policy decision and Nifty ended the day with a loss of 0.80 per cent below the 10,800 mark. The price action formed a bear candle carrying minor lower

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 05 DEC 2018

A morning walk down Dalal Street | RBI may maintain status-quo on rates with support for Nifty at 10,747. Indian Indices: It looks like the market has already priced in the uncertainty the way it has been moving in a narrow range since last Friday. Global Market: • Asian markets: Asian markets are lower today

TOP CORPORATE NEWS- 04 DEC 2018

Alembic Pharma subsidiary gets USFDA nod for Glycopyrrolate tablets Alembic Pharmaceuticals Ltd (Alembic), in a release to the exchanges on Tuesday, announced that its wholly-owned subsidiary Orit Laboratories LLC has received approval from the USFDA for its ANDA Glycopyrrolate tablets USP, 1 mg and 2 mg. According to IQVIA, Glycopyrrolate Tablets USP, 1 mg and

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 04 DEC 2018

Closing Bell: Sensex closes over 100 points lower, Nifty below 10,900; IT stocks gain. Shares have closed lower, amid caution ahead of RBI’s monetary policy committee meeting outcome on Wednesday. Uncertainty over US-China trade truce has also weighed on indices. Among sectors, weakness was visible among automobiles, banks, consumption and infrastructure names, while IT and

TOP CORPORATE NEWS- 03 Dec 2018

HUL’s food & refreshment biz to get a ‘boost’ as board approves GSK Consumer merger deal The board of Hindustan Unilever (HUL) has approved the scheme of amalgamating the company and GlaxoSmithKline (GSK) Consumer Healthcare Ltd (GSKCH), subject to further approvals. The transaction is an all-equity merger with 4.39 shares of HUL being allotted for

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 03 Dec 2018

The NSE benchmark Nifty on Friday extended its upmove for the fifth day in a row, but pared some of its gains to settle at 10,877, up by 0.17 per cent. The price action formed a high wave-like candle, indicating a breather post a sharp upmove. Going ahead, the zone of 10,710-10,780 is a crucial

CapitalStars FORUM